¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"genetic diabetes"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • genetic code
    À¯ÀüºÎÈ£
  • genetic counseling
    À¯Àü»ó´ã
  • genetic defect
    À¯Àü°á¼Õ
  • genetic determinant
    À¯Àü°áÁ¤ÀÎÀÚ
  • genetic disease
    À¯Àüº´
  • genetic disorder
    À¯ÀüÁúȯ
  • genetic drift
    À¯Àüº¯ÀÌ
  • genetic engineering
    À¯Àü°øÇÐ
  • genetic epidemiology
    À¯Àü¿ªÇÐ
  • genetic equilibrium
    À¯ÀüÀûÆòÇü
  • genetic female
    À¯ÀüÀû¿©¼º
  • genetic fitness
    À¯ÀüÀû¼ºµµ
  • genetic information
    À¯ÀüÁ¤º¸
  • genetic instability
    À¯ÀüºÒ¾ÈÁ¤
  • genetic interaction
    À¯Àü»óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diabetes decipiens
    °¡¼º´ç´¢º´
  • diabetes insipidus
    ¿äºØÁõ
  • diabetes intermittens
    °£Çæ´ç´¢º´
  • diabetes mellitus
    ´ç´¢º´
  • extrapancreatogenic diabetes
    ÀÌÀÚ¿Ü¿øÀδ索º´, ÃéÀå¿Ü¼º´ç´¢º´
  • genuine diabetes
    Áø¼º´ç´¢º´
  • gestational diabetes
    ÀӽŴ索º´
  • growth-onset diabetes
    Ãʱâ´ç´¢º´
  • iatrogenic diabetes
    ÀÇ¿ø´ç´¢º´
  • insulin-dependent diabetes
    Àν¶¸°ÀÇÁ¸´ç´¢º´
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • juvenile diabetes
    ¼Ò¾Æ´ç´¢º´
  • latent diabetes
    ÀáÀç´ç´¢º´
  • lipogenous diabetes
    Áö¹æ»ý¼º´ç´¢º´
  • lipuric diabetes
    Áö¹æ´¢´ç´¢º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • genetic disorders
    À¯Àü¼º Àå¾Ö(Áúȯ)(ë¶îîàõ î¡äô)
  • genetic drift
    À¯ÀüÀû ºÎµ¿(¡­Ý©ÔÑ).
  • genetic engineering
    À¯Àü°øÇÐ
  • genetic engineering
    À¯Àü°øÇÐ(ë¶îîÍïùÊ)
  • genetic factor
    À¯ÀüÀÎÀÚ
  • genetic factor
    À¯ÀüÀÎÀÚ(¡­ì×í­).
  • genetic factor
    À¯ÀüÀÎÀÚ.
  • genetic heterogeneity
    À¯Àü¼º ÀÌÁú¼º(¡­ì¶òõàõ)
  • genetic information
    À¯ÀüÁ¤º¸(¡­ï×ÜÃ).
  • genetic information
    À¯ÀüÁ¤º¸
  • genetic information
    À¯ÀüÁ¤º¸
  • genetic information
    À¯ÀüÁ¤º¸.
  • genetic interaction
    À¯ÀüÀû »óÈ£ÀÛ¿ë
  • genetic linkage
    À¯ÀüÀû °ü·Ã¼º(¡­Î¼Ö¤àõ).
  • genetic linkage
    À¯ÀüÀû °ü·Ã¼º.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • extrainsular diabetes
    µµ¿Ü¼º ´ç´¢º´(ÓöèâàõÓØèñÜ»).
  • extrapancreatogenic diabetes
    Ãé¿Ü¼º ´ç´¢º´(õýèâàõÓØèñÜ»).
  • genuine diabetes
    Áø¼º´ç´¢º´(òØàõÓØèñÜ»).
  • gestational diabetes
    Àӽżº ´ç´¢(º´)
  • gouty diabetes
    Åëdz¼º ´ç´¢º´.
  • growth onset type diabetes
    Ãʱâ´ç´¢º´.
  • hunger diabetes
    ±â¾Æ´ç´¢º´.
  • iatrogenic diabetes
    ÀÇ(¿ø)¼º ´ç´¢º´(ì¢ê«àõÓØèñÜ»), ÀÇÀμº ´ç´¢º´.
  • insulin deficiency diabetes
    Àν¶¸°°áÇ̼º ´ç´¢º´.
  • insulin dependent diabetes mellitus =IDDM
    Àν¶¸°ÀÇÁ¸¼º ´ç´¢º´.
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×¼º ´ç´¢º´.
  • intractable diabetes
    ³­Ä¡¼º ´ç´¢º´.
  • juvenile diabetes mellitus
    ¿¬¼Ò¼º ´ç´¢º´.
  • latent chemical diabetes
    ÀáÀ缺 È­ÇÐÀû ´ç´¢º´(íÖî¤àõûùùÊîÜÓØèñÜ»).
  • latent diabetes
    ÀáÀ缺 ´ç´¢º´(¡­ÓØèñÜ»).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • genetic system
    À¯Àü(ë¶îî) ½Ã½ºÅÛ
  • mobile genetic elements
    À̵¿À¯Àü¿ä¼Ò(ì¹ÔÑë¶îîé©áÈ)
  • random genetic drift
    ¹«ÀÛÁ¤ À¯Àü Ç¥·ù(ÙííÂïÒë¶îîø÷×µ)
  • somatic cell genetic engineering
    ü¼¼Æ÷ À¯Àü°øÇÐ(ô÷á¬øàë¶îîÍïùÊ)
  • transposable genetic element
    ÀüÄ¡À¯Àü¿ä¼Ò (ï®öÇë¶îîé©áÈ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GT gait training; galactosyl transferase; gastrostomy; generation time; genetic therapy; gingiva treatm...
HGMCR human genetic mutant cell repository
IGA infantile genetic agranulocytosis
VG genetic variance
DI   1) Diabetes Insipidus
  2) Discomfort Index; ºÒÄè Áö¼ö
   &nb...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
db Diabetes
DCCT Diabetes Control and Complication Trial
DI Diabetes Insipidus
DM Diabetes Mellitus
DM2 Diabetes Mellitus
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
diabetes and fibre Soluble fibres (oat bran, apples, citrus, pears, peas/beans, psyllium, etc.) slow down the digestion of carbohydrates (sugars), which results in better glucose metabolism. Some patients with the adult-onset diabetes may actually be successfully treated with a high-fibre diet alone, and those on insulin, can often reduce their insulin requirements by adhering to a high-fibre diet.
(12 Dec 1998)
diabetes, gestational A diabetic condition that appears during pregnancy (gestation) and may go away after the birth of the baby.
(12 Dec 1998)
diabetes innocens The recurring or persistent excretion of glucose in the urine, in association with blood glucose levels that are in the normal range; results from the failure of proximal renal tubules to reabsorb glucose at a normal rate from the glomerular filtrate (low renal threshold); defect in the glucose carrier in the nephron.
Synonym: diabetes innocens, normoglycaemic glycosuria, renal diabetes.
(05 Mar 2000)
diabetes insipidus <disease, endocrinology> Rare form of diabetes in which the kidney tubules do not reabsorb sufficient water. This can be because (a) either the renal tubules have defective receptors for antidiuretic hormone (ADH, vasopressin) or (b) a class of aquaporin water channel in the collecting duct is defective or (c) there is inadequate ADH production by the pituitary, leading to the excessive production of dilute urine.
(18 Nov 1997)
diabetes insipidus, nephrogenic A rare congenital and familial form of diabetes insipidus, resulting from failure of the renal tubules to absorb water. There is excessive production of antidiuretic hormones but the tubules fail to respond to it.
(12 Dec 1998)
diabetes intermittens Diabetes mellitus in which there are periods of relatively normal carbohydrate metabolism followed by relapses to the previous diabetic state.
(05 Mar 2000)
diabetes mellitus <disease> Relative or absolute lack of insulin leading to uncontrolled carbohydrate metabolism. In juvenile onset diabetes (that may be an autoimmune response to pancreatic _ cells) the insulin deficiency tends to be almost total, whereas in adult onset diabetes there seems to be no immunological component but an association with obesity.
(18 Nov 1997)
diabetes mellitus, experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by pancreatectomy.
(12 Dec 1998)
diabetes mellitus, insulin-dependent Diabetes mellitus characterised by insulin deficiency, sudden onset, severe hyperglycaemia, rapid progression to ketoacidosis, and death unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
(12 Dec 1998)
diabetes mellitus, lipoatrophic A disorder characterised by complete absence of subcutaneous adipose tissue, insulin-resistant diabetes with little tendency to ketoacidosis, hyperlipidemia with subcutaneous xanthomatosis, hepatomegaly, and an elevated basal metabolic rate.
(12 Dec 1998)
diabetes mellitus, non-insulin-dependent Diabetes characterised by the ability to survive without ketoacidosis in the absence of insulin therapy. It is usually of slow onset and patients exhibit a tendency to obesity.
(12 Dec 1998)
diabetes related peptide <hormone, protein> Peptide of 37 amino acids that selectively inhibits insulin stimulated glucose uptake in muscle. Structurally related to calcitonin gene-related peptide.
(15 Oct 1997)
diabetes, type 1 Insulin dependent diabetes or juvenile diabetes.
(12 Dec 1998)
diabetes, type 2 Non-insulin dependent diabetes, adult-onset diabetes or insulin-resistant diabetes.
(12 Dec 1998)
insulin dependent diabetes A form of diabetes that requires the daily injection of the hormone insulin to maintain normal body chemistry. Avoidance of insulin in these patients will result in a severe metabolic derangement known as diabetic ketoacidosis.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á